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Objective: We evaluated the relationship of medial proximal tibial periarticular areal bone mineral
density (paBMD) and trabecular morphometry and determined whether these bone measures differed
across radiographic medial joint space narrowing (JSN) scores.
Methods: 482 participants of the Osteoarthritis Initiative (OAI) Bone Ancillary Study had knee dual X-ray
absorptiometry (DXA) and trabecular bone 3T magnetic resonance imaging (MRI) exams assessed at the
same visit. Medial proximal tibial paBMD was measured on DXA and apparent trabecular bone volume
fraction (aBV/TV), thickness (aTb.Th), number (aTb.N), and spacing (aTb.Sp) were determined from MR
images. Radiographs were assessed for medial JSN scores (0e3). We evaluated associations between
medial paBMD and trabecular morphometry. Whisker plots with notches of these measures versus
medial JSN scores were generated and presented.
Results: Mean age was 63.9 (9.2) years, BMI 29.6 (4.8) kg/m2, and 53% were male. The Spearman
correlation coefﬁcients between DXA-measured medial paBMD and aBV/TV was 0.61 [95% conﬁdence
interval (CI) 0.55e0.66]; between paBMD and aTb.Th was 0.38 (95%CI 0.30e0.46); paBMD and aTb.N was
0.65 (95%CI 0.60e0.70); paBMD and aTb.Sp was 0.65 (95%CI 0.70 to0.59). paBMD and the trabecular
metrics were associated with medial JSN scores.
Conclusion: The moderate associations between periarticular trabecular bone density and morphometry
and their relationship with greater severity of knee OA support hypotheses of remodeling and/or
microscopic compression fractures in the natural history of OA. Longitudinal studies are needed to assess
whether knee DXA will be a predictor of OA progression. Further characterization of the periarticular
bone in OA utilizing complementary imaging modalities will help clarify OA pathophysiology.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
There is strong evidence that periarticular bone abnormalities
(e.g., sclerosis, bone marrow lesions, and attrition) are pathologic
in osteoarthritis (OA)1e6. Evaluation of the periarticular bone usingf the author(s) and do not
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r Ltd on behalf of Osteoarthritis Rediverse imaging modalities has the potential to increase our
understanding of OA pathology occurring in this structure.
A number of OA features, including sclerosis and bone marrow
lesions, have been associated with local changes in bone mineral
density (BMD)7e11. One method of assessing local BMD changes in
a given region of interest (ROI) is with dual X-ray absorptiometry
(DXA) which provides a measure of apparent tibial periarticular
areal BMD (paBMD) deﬁned as [(mineralization within a ROI)
divided by (area of the ROI)].
High-resolution magnetic resonance imaging (MRI) allowing for
in vivo evaluation of trabecular bone can be obtained with
parameters that optimize visualization of these structures12e16. In
Fig. 1, we show an example MR image from a knee with moderatesearch Society International.
Fig. 1. Trabecular magnetic resonance image of a knee with medial tibiofemoral OA
JSN grade 3. Marrow fat appears white (high-intensity signal) while bone appears
black (no signal). The white rectangle is a sample ROI.
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(e.g., appears white) while bone has no signal (e.g., appears black).
Using this image contrast, there is an opportunity to calculate
apparent trabecular bone volume fraction (aBV/TV), deﬁned as
trabecular bone volume divided by total ROI volume, as well as
apparent morphometric assessments of trabecular number (aTb.N),
thickness (aTb.Th) and spacing (aTb.Sp.).
Knee DXA has the potential to predict OA progression and
therefore indicates the need for early and/or preventative treat-
ment. This study serves to provide initial validation needed to
support the use of knee DXA in this manner. By obtaining knee
DXAs, trabecular MRIs, and knee X-rays on the same joint and at the
same time point, we have the opportunity to better understand
structural patterns that underlie the previously reported greater
paBMD in those with greater knee OA severity7,8. Therefore, the
goals of this study were (1) to evaluate the relationship of medial
tibial paBMD as measured by DXAwith medial tibial aBV/TV, aTb.N,
aTb.Sp, and aTb.Th as measured by MRI and (2) to evaluate each
measure subgrouped across medial tibial-femoral joint space nar-
rowing (JSN) scores, a radiographic measure of OA severity.
Methods
Study design
This is a cross-sectional study of a convenience sample of
participants of the Bone Ancillary Study, an ancillary study to the
Osteoarthritis Initiative (OAI), including only those with complete
OAI 30 or 36 months knee DXAs and trabecular MR morphometry
metrics and OAI 36 months radiographic medial JSN readings.
Sample selection
The OAI is a publicly available multi-center observational study
of knee OA of 4796 participants, which is comprised three groups
classiﬁed at baseline, the progression (N ¼ 1389), the incidence
(N ¼ 3285), and a nonexposed control group (N ¼ 122). The
“progression subcohort” all have pre-existent symptomaticradiographic knee OA (ROA), the “incident subcohort” are at
increased risk for developing symptomatic ROA, and the “nonex-
posed control subcohort” do not have knee pain or ROA in either
knee and do not have risk factors for knee OA17.
The Bone Ancillary Study is nested within the OAI and involves
members of the progression subcohort. These subjects met the
subcohort’s inclusion criteria of age 45e79 years; and had at least
one knee with both radiographic evidence of knee OA [Osteoar-
thritis Research Society International (OARSI) atlas18 osteophyte
grade 1e3] and symptoms (“pain, aching or stiffness on most days
of the month in the last year”) at their OAI study baseline visit.
Those with evidence of severe JSN, as deﬁned by OARSI atlas18 JSN
grade 3, in both knees were excluded.
Participants were enrolled into the Bone Ancillary Study
(N¼ 629) during their 30 months or 36 months OAI follow-up visit.
The purpose of the Bone Ancillary Study was to evaluate the
inﬂuence of bone measures on longitudinal structural progression.
The ﬁnal results of the Bone Ancillary Study are not yet available.
Inclusion criteria for the Bone Ancillary Study were that partici-
pants were agreeable to having the additional assessments of knee
trabecular MRI and DXA. Exclusion criteria into the Bone Ancillary
Study were contraindication for MRI and the presence of bilateral
knee replacements. At the time of enrollment into the Bone
Ancillary Study, participants had a knee DXA scan and a knee
trabecular MRI of the same knee. The participants of the study
presented in this manuscript include those of the Bone Ancillary
Study with complete baseline (OAI 30 or 36 months) knee DXA and
trabecular morphometry metrics, and medial JSN data from OAI
36 months plain radiographs.
MRI
Participants had unilateral knee trabecular MRI exams on one of
the four identical Siemens Trio 3T MRI systems at the clinical sites,
Memorial Hospital of Rhode Island (Pawtucket, RI) Ohio State
University (Columbus, Ohio), University of Pittsburgh (Pittsburgh,
PA), and University of Maryland/Johns Hopkins University (Balti-
more, MD). The right knee was usually scanned unless this knee
was replaced or there was a contraindication for an MRI of this
knee, in which case, the left knee was scanned.
Coronal-oblique 3D fast imaging with steady state precision
(FISP) was used to visualize the periarticular trabecular bone.
Images were obtained in 10.5 min using 72 slices, 1 mm slice
thickness, 0.23 mm  0.23 mm in-plane spatial resolution, 12 cm
ﬁeld of view, 512  512 matrix (interpolated to 1024  1024),
4.92 ms echo time (fat-water in-phase), 20 ms recovery time, 50
ﬂip angle, 180 Hz/pixel readout bandwidth, and phase encode
right/left. Interpolation does not change the measured spatial
resolution, but does change the displayed spatial resolution. It does
not affect metrics taken from the images. The chemical shift artifact
(signal void in the distal femur) was 2.4 pixels, intentionally shifted
superiorly so that it was outside the femoral subchondral bone and
the tibial ROI.
Trabecular MR image analysis
One analyst (AT) determined all the tibial trabecular
morphometry metric values (aBV/TV, aTb.N, aTb.Th, and aTb.Sp)
using an established proprietary software, calcDCN used in prior
research studies to evaluate bone in osteoporosis and OA13e15,19e22.
AT placed a rectangular ROI in the proximal medial tibia immedi-
ately adjacent to the articular cartilage. We focused on the medial
compartment as medial tibiofemoral OA is more common that
lateral OA. The ROI had a height of 3.75 mm and awidth that varied
from 14e17 mm depending on the size of the knee, and was placed
Fig. 2. DXA of the same knee scanned in Fig. 1 with medial tibiofemoral OA with JSN
grade 3. The red rectangle bounded by the yellow bone border is the ROI used to
measure the medial tibial paBMD.
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Details of the software algorithms used to derive thesemetrics have
been reported22. In brief, aBV/TV is the percent of the number of
pixels contributing to the bone signal void normalized to the total
number of pixels in the ROI. The aTb.Th is determined using the
mean value of the mean intercept length for all angles through
a given image, measured in millimeters. The aTb.N is calculated by
dividing the aBV/TV by aTb.Th. And ﬁnally, aTb.Sp is calculated
using the equation (1/aTb.N)  aTb.Th. An average of each of the
metrics was taken across the 20 ROIs within one knee. Intra-rater
(measurementeremeasurement) reliability was good with intra-
class correlations (ICC): 0.97 [95% conﬁdence interval (CI)
0.91e0.99] for aBV/TV, 0.98 (95%CI 0.92e0.99) for aTb.Th, 0.92 (95%
CI 0.73e0.98) for aTb.N, and 0.77 (95%CI 0.38e0.93) for aTb.Sp. For
the reliability sample, N¼ 12 inclusive of all clinical sites, with each
pair of scans being assessed at least 3 days apart. The reliability
sample included some volunteers whowere not part of the OAI and
hence were not screened for the presence or absence of symptoms
or radiographic OA. The measurement range and standard devia-
tion (SD) of the testeretest analysis differences were as follows: for
aBV/TV, the smallest and largest paired differences were 0.019
and 0.061 and SD of the differences was 0.022; for aTb.Th, the
smallest and largest paired differences were 0.009 and 0.010 and
SD of the differences was 0.007; for aTb.N, the smallest and largest
paired differences were0.078 and 0.398 and SD of the differences
was 0.128; and for aTb.Sp, the smallest and largest paired differ-
ences were 0.527 and 0.123 and SD of the differences was 0.169.
Tibial plateau DXA
The proximal tibiae were evaluated using one of the four iden-
tical DXA scanners (Lunar Prodigy Advance scanner, GE Lunar Corp.,
Madison WI, USA) at the four clinical sites with investigational
knee software (enCORE 2007 Version 11.20.068) provided by the
manufacturer. The lower extremity was positioned with the long
axis of the tibia perpendicular to the X-Ray beam, and neutrally
rotated. A foam positioner was placed posterior to the popliteal
fossa to put the knee in mild ﬂexion. The ipsilateral foot was then
placed into the foot-positioner and securely wrapped with the
velcro strap around the perimeter of the foot and the positioner.
This positioning resulted in the ipsilateral toes perpendicular to
the scanning bedwith the plantar surface of the foot adjacent to the
perpendicular edge of the positioner which was parallel to the
lower border of the scanner bed. The positioning laser light was
used to center the scanner arm 5 cm below the inferior pole of the
patella. The knee was then imaged by the DXA scanner. A sample
image is seen in Fig. 2.
Tibial plateau BMD measurements
The height of each proximal medial tibial ROI was ﬁxed at
10 mm while the ROI width in the medio-lateral direction was set
as ½ the distance between the medial and lateral bone edges
along a line midway between the far medial and lateral points of
the tibial plateau (Fig. 2). The length of bone edges served as the
outer dimension of the ROIs. The ROIs were positioned so that
their top edges were just superior and parallel to the medial joint
surfaces of the tibia. The scanerescan (with repositioning) ICC was
0.997 (95%CI 0.992e0.999) for the right medial tibial areal BMD
evaluating a sample of 10 individuals. The reliability sample
included some volunteers who were not part of the OAI and hence
were not screened for the presence or absence of symptoms or
radiographic OA. The smallest and largest paired remeasurement
differences were 0.026 and 0.031 and SD of the paired differ-
ences was (0.017).Plain radiographs of the knee
Aweight-bearing, bilateral, ﬁxed ﬂexion posterioreanterior (PA)
radiograph of the knees was obtained at the OAI 36 months visit.
These images were scored for JSN grade (0e3) using the OARSI
atlas18 [weighted kappa (intra-rater reliability) ¼ 0.88 (95%CI
0.80e0.95)] by the Boston University X-ray reading group, results
that were made publicly available on the OAI website (http://oai.
epi-ucsf.org/datarelease/) with the ﬁlename, kXR_SQ_BU05_SAS,
Version 5.4.
Statistical analysis
Because only unilateral trabecular MR images were acquired, we
focused all our analyses on this knee. We performed Spearman’s
correlations and created scatter plots of medial paBMD versus all
apparent trabecular morphometry metrics (average of the 20 slices
evaluated on each MRI). Whisker plots with notches of paBMD and
the trabecular morphometry measures versus medial JSN scores
were generated and presented. The KruskaleWallis test was used to
generate global P-values for these comparisons. If the global test
was statistically signiﬁcant, pairwise comparisons weremade using
the ManneWhitney U test; the medial JSN ¼ 0 group was the
referent group. All analyses were performed using SAS version 9.2
with the exception of the ICC calculations which were performed
using SPSS version 19. P-values <0.05 were considered statistically
signiﬁcant.
Results
482 participants were included in this study. The mean age was
63.9 (9.2) years, BMI 29.6 (4.8) kg/m2, and 53% were male. Of the
knees studied, 466 (97%) were right knees, and 16 (3%) were left.
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a JSN of 2, and 29 with a JSN of 3.
Figure 3 illustrates scatter plots of paBMD versus the trabecular
morphometry measures of all participants. The Spearman correla-
tion coefﬁcients between the medial paBMD and aBV/TV, aTb.N,
aTb.Th, and aTb.Sp were 0.61, 0.65, 0.38, and 0.65 respectively,
each with P < 0.0001.
The overall comparison evaluating paBMD and MRI trabecular
measures across medial JSN scores was statistically signiﬁcant
(Fig. 4). Pairwise comparisons indicated that paBMD, aBV/TV,
aTb.N, and aTb.Th were statistically greater among knees with
higher medial JSN scores (JSN ¼ 2 and JSN ¼ 3) than knees with
medial JSN ¼ 0. Pairwise comparisons also showed that for paBMD,
aBV/TV, and aTb.N, knees with medial JSN ¼ 1 versus JSN ¼ 0 had
also statistically greater values. aTb.Sp was statistically signiﬁcantly
lower in knees with higher medial JSN (JSN ¼ 1e3) compared with
knees having a JSN ¼ 0.
Discussion
In this study of the proximal medial tibial periarticular bone, the
areal paBMD measured by DXA correlated positively with aBVF,
aTb.N, and aTb.Th and negatively with aTb.Sp. Further, each of these
measures was also associated with medial JSN score, a radiographic
marker of OA severity.Fig. 3. Scatter plots (N ¼ 482) of the proximal medial tibial paBMD (g/cm2) determined by D
apparent trabecular number (aTb.N) (1/mm), (c) apparent trabecular thickness (aTb.Th) (mm
knee medial JSN scores.Elevated apparent paBMD, as measured by DXA, has been
associated with many features of OA including osteophytes8, JSN8,
sclerosis8, bone marrow lesions7, meniscal damage23, and longitu-
dinal JSN10,24. We conﬁrmed that elevated paBMD is associated
with medial JSN as well as with periarticular apparent trabecular
measures ascertained using MRI. Apparent BMD has been associ-
ated with bone stiffness25, a characteristic of bone that has been
implicated in OA pathophysiology26. Our ﬁndings that higher
paBMD was associated with greater aBV/TV, aTb.N, and aTb.Th and
lower aTb.Sp, each of which was correlated with greater medial JSN
suggesting potential pathologic etiologies for these ﬁndings
including bone remodeling or small compression fractures (e.g.,
microcracks) occurring in these regions of periarticular bone6,27. A
histologic study of osteoarthritic hips removed at the time of joint
replacement corroborates our ﬁndings showing that DXA-
measured BMD and histomorphometry measured bone volume
fraction are highly correlated r ¼ 0.77e87, P < 0.00128. Further-
more, evidence of microdamage, including microcracks and
microfractures, was frequently observed in histologic samples of
osteoarthritic joints at the time of replacement28e30.
To our knowledge, there have been two reports evaluating MRI
trabecular morphometry as it relates to knee OA severity though
the relationship with paBMD measured by DXA was not evaluated.
Blumenkrantz et al. showed an opposite ﬁnding to ours where
medial tibial bone in those knees withmore severe radiographic OAXA, versus MRI measured (a) the tibial apparent bone volume fraction (aBV/TV), (b) the
), (d) the apparent trabecular spacing (aTb.Sp) (mm). The points are color coded to the
Fig. 4. Whisker plots with notches by medial JSN score of (a) proximal medial tibial paBMD, (b) apparent bone volume fraction (aBV/TV), (c) apparent trabecular number (aTb.N) (1/
mm), (d) apparent trabecular thickness (aTb.Th) (mm), and (e) apparent trabecular spacing (aTb.Sp) (mm). Values above whisker plots are median values in the respective medial
JSN groups. *Denotes statistically signiﬁcant difference (P < 0.05) compared to the referent group, knees with a medial JSN score ¼ 0.
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radiographic OA14. However, this study was small (N ¼ 30) and
utilized axial 1.5 T MR images which did not allow visualization of
sub-articular tibial bone. In our study, the coronal oriented MR
acquisition facilitated visualization of this portion of bone, likely
most relevant in knee OA pathophysiology. Chiba et al. evaluated 60
participants and studied periarticular trabecular measures based
on MR images and radiographic evidence of OA31. That study
employed sagittal 3 T MR images which allowed evaluation of
trabecular bone adjacent to the articular cartilage in a manner
similar to ours and found similar results to ours; greater medial
tibial JSN was associated with a greater aBV/TV and aTb.Th, and
lower aTb.Sp. The results for aTb.N were similar but not statistically
signiﬁcant. In a study evaluating trabecular spacing on radiographs
in people with knee OA who were candidates for joint replace-
ments, Wong et al. found trabecular spacing was positivelyassociated with joint space width such that narrower joint space
was correlated with lower trabecular spacing32 similar to what we
found in this study.
An important limitation to our study is that the measures of
trabecular morphometry are based onMR images and are not direct
assessments of histomorphometry. In addition two of the trabecular
morphometry metrics, aTb.N and aTb.Th, were derived from the
other two, aBV/TV andaTb.Sp. However,manyof the results fromthis
study are consistent with prior studies that performed direct histo-
logic evaluation in OA. Li et al. evaluated femoral head specimens
(N¼ 16) obtained at the time of total hip replacement and compared
them to post-mortem samples of asymptomatic hips (N¼ 7)25. They
evaluated bone volume fraction as it relates to apparent BMD, the
histologic equivalent to themeasure of BMDDXAprovides. Similar to
our ﬁndings, they found that those with OA had a higher apparent
BMD and a higher bone volume fraction compared to normal
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early knee OA (N ¼ 10) compared to normal knees (N ¼ 10)33. There
have been two additional studies evaluating knee trabecular histo-
morphometry including not only bone volume fraction, but also
trabecular number, thickness, and spacing assessments. Kamibaya-
shi et al. evaluated 11 medial tibiae from 10 patients collected from
hemi- and total arthroplasties for knee OA, all of whom had varus
alignment and compared these knees to four age-matched
controls34. In that study, the OA samples had a much higher bone
volume fraction compared to the normal knees and the trabecular
thickness was higher in the OA samples compared to normal knees
which are consistent with the ﬁndings in our study. However in
contrast to ourﬁndings, trabecular numberwas lower and trabecular
spacing was higher in OA knees compared to normal knees though
the differences were not statistically signiﬁcant. Bobinac et al. eval-
uated 10 tibial plateaus taken at total knee arthroplasties from 10
patientswith kneeOA (mean age 62.5 years)e all ofwhomhad varus
malalignment35. The bone volume fraction, trabecular thickness and
trabecular number were greater while the trabecular spacing was
lower in the medial tibia compared with the lateral tibia, consistent
with the ﬁndings in our study.
A study evaluating MRI-measured morphometry measures
against the direct histology would be helpful in clarifying the val-
idity of MRI-based measures, particularly the aTb.N and aTb.Sp
given the conﬂicting reports regarding these measures in the
current literature for knees with OA. However, the large sample size
is a strength of this compared to prior studies. Further, we found
the aTb.N and aTb.Sp associated with an established measure of
structural severity, medial JSN, giving us conﬁdence that we
have reported the correct direction of bone change associated
with disease severity. A signiﬁcant beneﬁt to MRI-measured
morphometry is that this non-invasive method lends itself to use
in large clinical studies at multiple time points. This is in contrast to
the limited size histologic studies that can only be evaluated at
single time points given the invasive nature of those studies.
When evaluating scatter plots of the trabecular metrics versus
the paBMD of the medial tibia subgrouped by medial tibiofemoral
JSN, we observed points representing the highest values for aBV/TV,
aTb.N, and aTb.Th all include knees with greater JSN severity.
Therefore, one potential biologic explanation is that once the
disease is initiated, an additional process in bone may occur that
reduces the association between DXA and trabecularmorphometry.
For instance, perhaps prior to initiation of OA, DXA approximates
morphometry with a ﬁxed macrostructure. Once OA initiates, the
periarticular bone is then subjected to some process such as
remodeling or subchondral compression of bone that alters the
previously ﬁxed macrostructure. This however, is conjecture and
the data from this study cannot conﬁrm or refute this possibility.
Additional limitations to our study include that the ROI on the
trabecular MR images was not replicated on the DXA images due to
constraints of the DXA software and it was not possible to exclude
anterior and posterior osteophytes from the DXA ROIs because of
the projectional nature of the X-rays used to acquire these images.
Also, the ROI height could potentially affect the qMRI metrics as
they reﬂect an average of the bone assessed within the ROI.
Therefore, if there was heterogeneity in the bone within the ROI,
the qMRI metrics could change if the height of the ROI was modi-
ﬁed.We chose a small ROI height becausewewanted to capture the
part of the bone that seemed most dynamic in those with knee OA.
The expectation was that a smaller ROI height would minimize the
heterogeneity within the ROI. Even with these limitations, the
correlations between the DXA acquired paBMD and the MRI
trabecular measures were moderate to strong, suggesting that the
DXA and MRI regions were similar enough to depict the same
biological/pathological process.This study corroborates prior ﬁndings identifying that peri-
articular bone pathology is associated with greater OA sever-
ity2e5,36,37. Radin et al. found that trauma induced periarticular
bone changes in rabbits can predicate damage in cartilage38. If
periarticular bone pathologic changes can be slowed or even hal-
ted, perhaps there is an opportunity to limit articular cartilage
damage. Observational data suggests that vitamin D, an important
nutrient for bone health, could prove to be beneﬁcial; those with
a higher vitamin D level were less likely to have progression of knee
OA39.We are awaiting ﬁnal results from two randomized controlled
clinical trials of vitamin D in the treatment of knee OA that will
hopefully address its efﬁcacy as a disease modifying OA drug.
Although there has been observational data suggesting treatment
with bisphosphonates might be beneﬁcial in OA40, the randomized
controlled trial evaluating this treatment did not conﬁrm its efﬁ-
cacy41. Perhaps this treatment was not effective because it targeted
the catabolic activity in bone. Targeting the anabolic activity of
bone may be a better strategy. There was a recent animal study
supporting that the treatment with parathyroid hormone reduced
cartilage scores on histology42. To date, there have not been human
studies of parathyroid hormone or its analogs in the treatment of
knee OA.
In summary, medial tibial paBMD and local trabecular
morphometry measures are moderately associated with one
another and each is associated with medial JSN, a radiographic
marker of OA severity. Knees with higher JSN scores have higher
medial paBMD, aBV/TV, aTb.Th, and aTb.N, and lower aTb.Sp. Knee
DXA correlates with trabecular morphometry and JSN severity
cross-sectionally; longitudinal studies are needed to assesswhether
knee DXA will be a predictor of OA progression and serve as an
indicator for those who might beneﬁt from early and/or preventa-
tive treatment. Further characterization of the periarticular bone in
OA and pre-OA states, including evaluation of these measures with
basic participant characteristics, utilizing complementary imaging
modalities will help clarify OA pathophysiology.
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